Search Results - "Hullin, R"

Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients by Soborun, N., Müller, M., Abdurashidova, T., Tzimas, G., Schukraft, S., Lu, H., Hugli, O., Vollenweider, P., Garnier, A., Monney, P., Hullin, R.

“…Hospitalization for heart failure treatment (HHF) is an incisive event in the course of HF. Today, the large majority of HHF patients is ≥ 65 years and…”
Get full text

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease by Rossignol, P., Silva-Cardoso, J., Kosiborod, MN, Brandenburg, V., Cleland, JG, Hadimeri, H., Hullin, R., Makela, S., Mörtl, D., Paoletti, E., Pollock, C., Vogt, L., Jadoul, M., Butler, J.

“…Pivotal randomized trials demonstrating efficacy, safety and good tolerance, of two new potassium binders (patiromer and sodium zirconium cyclosilicate) led to…”
Get full text

Churg-Strauss syndrome with cardiac involvement: case illustration and contribution of CMR in the diagnosis and clinical follow-up by d'Ersu, E., Ribi, C., Monney, P., Vincenti, G., Schwitter, J., Rotman, S., Hullin, R., Regamey, J.

“…This report summarises three cases of Churg-Strauss syndrome (CSS) illustrating the diagnostic challenges associated with the cardiac manifestation of this…”
Get full text

SUN-PP151: Association between Nutritional Status and Disease Severity in Outpatients with Chronic Systolic Heart Failure by Makhlouf, A.-M, Thibault, R, Mondouagne, L.P, Testuz, A, Trentaz, F, Hullin, R, Pichard, C, Meyer, P

Get full text

MON-PP143: A Medical and Nursing Training Focused on a Specific Group of Patients Improves General Nutritional Practices in a University Hospital by Kouadio, A, Guex, E, Larche, M, Raya, A, Sartori, C, Hullin, R, Schafer, M, Cerantola, Y, Morisod, B, Hurni, M, Michel, P, Pralong, F, Depraz Cissoko, M.-P, Coti Bertrand, P

Get full text

Diastolic Dysfunction of the Cardiac Allograft and Maximal Exercise Capacity by Roten, L., MD, Schmid, J.-P., MD, Merz, F., MD, Carrel, T., MD, Zwahlen, M., PhD, Walpoth, N., MD, Mohacsi, P., MD, Hullin, R., MD

“…Background Peak oxygen uptake (peak V o2 ) is an established integrative measurement of maximal exercise capacity in cardiovascular disease. After heart…”
Get full text

Diastolic Dysfunction in Human Cardiac Allografts is Related with Reduced SERCA2a Gene Expression by Stüdeli, R., Jung, S., Mohacsi, P., Perruchoud, S., Castiglioni, P., Wenaweser, P., Heimbeck, G., Feller, M., Hullin, R.

“…Previous studies demonstrated that impaired left ventricular (LV) relaxation in cardiac allografts limits exercise tolerance post‐transplant despite preserved…”
Get full text

Cytokine Activation and Disease Progression in Patients With Stable Moderate Chronic Heart Failure by Tanner, H., MD, Mohacsi, P., MD, Fuller-Bicer, G.A., MD, Rieben, R., PhD, Meier, B., MD, Hess, O., MD, Hullin, R., MD

“…Background Activation of the cytokine and the complement system is associated with disease progression in severe congestive heart failure (CHF). Magnitude and…”
Get full text

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins by Boekstegers, P, von Degenfeld, G, Giehrl, W, Heinrich, D, Hullin, R, Kupatt, C, Steinbeck, G, Baretton, G, Middeler, G, Katus, H, Franz, W M

“…Catheter-based percutaneous transluminal gene delivery (PTGD) into the coronary artery still falls behind the expectations of an efficient myocardial gene…”
Get full text

Calcium channel beta subunit heterogeneity: functional expression of cloned cDNA from heart, aorta and brain by Hullin, R., Singer‐Lahat, D., Freichel, M., Biel, M., Dascal, N., Hofmann, F., Flockerzi, V.

“…Complementary DNAs encoding three novel and distinct beta subunits (CaB2a, CaB2b and CaB3) of the high voltage activated (L‐type) calcium channel have been…”
Get full text

Pre-eclampsia with acute heart failure postpartum as primary manifestation of systemic lupus erythematosus by Hildbrand, P., Eigenmann, C., Gugger, M., Marti, H.P., Hullin, R.

“…Pre‐eclampsia occurs in 2–5% of pregnancies of healthy women. Here, we present a rare case of pre‐eclampsia with overt acute heart failure, which was the…”
Get full text

Stratification risk computation of primary graft gysfunction in heart transplant recipients on a smartphone application by Ait Tigrine, S, Hoti, E, Hullin, R, Kirsch, M, Tozzi, P

“…Abstract Introduction There are no standardized guidelines for helping graft allocation in heart transplant (HTx) and accepting transplants from marginal…”
Get full text

Pretransplant erythroferrone levels are predictive of 1-year all-cause mortality or acute rejection after heart transplantation by Pitta Gros, B, Rocca, A, Laptseva, N, Flammer, A, Martinelli, M, Meyer, P, Leuenberger, N, Muller, M, Hullin, R

“…Abstract Background/Introduction Heart transplantation (HTx) remains the treatment of choice for selected advanced heart failure (HF) patients. Iron deficiency…”
Get full text

Clinical characteristics, management, and outcomes of acute heart failure patients in Central Asia by Abdurashidova, T, Muller, M, Dzhorupbekova, K, Kaliev, K, Chazymova, Z, Toktosunova, A, Beishenkulov, M, Kirsch, M, Hullin, R

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Cardiovascular disease (CVD) is the leading cause of death in Central Asia. In…”
Get full text

(835) Preoperative Levosimendan to Reduce Risk of Right Ventricular Failure after LVAD Surgery by Godinho, R., Nowacka, A., Aur, S., Regamey, J., Ltaief, Z., Rusca, M., Hullin, R., Liaudet, L., Kirsch, M., Yerly, P.

“…Right ventricular failure (RVF) is frequent after left ventricular assist device (LVAD) implantation and associated with high mortality. Because of decreased…”
Get full text

(798) Safety of Levosimendan Infusion Before LVAD Implantation. A Retrospective Study by Godinho, R., Nowacka, A., Aur, S., Regamey, J., Ltaief, Z., Rusca, M., Hullin, R., Liaudet, L., Kirsch, M., Yerly, P.

“…With its long lasting inotropic effect, preoperative levosimendan (LEVO) was proposed to prevent right ventricular failure (RVF) after left ventricular assist…”
Get full text

Regional Expression and Functional Characterization of the L-type Ca2+-Channel in Myocardium from Patients with End-stage Heart Failure and in Non-failing Human Hearts by Schwinger, R.H.G., Hoischen, S., Reuter, H., Hullin, R.

“…The purpose of the present study was to investigate the expression and functional relevance of sarcolemmal L-type Ca2+-channels in failing and non-failing…”
Get full text

P788Discharge echocardiographic parameters of RV and LV function but not of changes in cardiac unloading are related to 12-month prognosis during hospitalization for acute decompensated heart failure by Monney, P, Barras, N, Tzimas, G, Abdurashidova, T, Regamey, J, Yerly, P, Hugli, O, Hullin, R

“…Abstract Introduction Acute decompensated heart failure (ADHF) is associated with a high mortality and rehospitalization rate. The aim of this study was to…”
Get full text

Heart transplantation: current practice and outlook to the future by Hullin, Roger

“…The field of heart transplantation has seen substantial progress in the last 40 years. The breakthroughs in long-term survival were followed by a period of…”
Get full text

Informal caregivers involvement in heart failure self-care: perceived acceptability and contribution to heart failure self-care from a feasibility quasi-experimental study by Santos, G, Liljeroos, M, Tschann, K, Denhaerynck, K, Wicht, J, Jurgens, C Y, Hullin, R, Schafer-Keller, P

“…Abstract Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): HES-SO University of Applied Sciences and Arts…”
Get full text